A Systematic Review of Magnesium Therapy for Treating Attention Deficit Hyperactivity Disorder

被引：0
作者：
Ghanizadeh, Ahmad [1 ,2 ]
机构：
[1] Shiraz Univ Med Sci, Res Ctr Psychiat & Behav Sci, Sch Med, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Psychiat, Shiraz, Iran
来源：
ARCHIVES OF IRANIAN MEDICINE | 2013年 / 16卷 / 07期
关键词：
Attention Deficit Hyperactivity Disorder (ADHD); drug therapy; magnesium; review; trace elements; NERVOUS-SYSTEM; CHILDREN; ADULTS; BRAIN; ZINC; SUPPLEMENTATION; PEMOLINE; DEXTROAMPHETAMINE; METHYLPHENIDATE; METABOLISM;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
There are contradictory reports about the association of magnesium and attention- deficit hyperactivity disorder (ADHD). Moreover, some studies reported that magnesium is effective for treating ADHD. This is the first systematic review evaluating the effectiveness of magnesium to treat patients with ADHD. The two databases of MEDLINE/ PubMedline and Google Scholar were electronically searched using the search items and considering inclusion and exclusion criteria. Out of the 37 titles, only six studies were experimental interventional studies. However, three of these studies were without any control group. The other three studies were controlled clinical trials. Nevertheless, none of the studies was a randomized double- blind controlled clinical trial. These studies supported that magnesium is effective for treating ADHD. Magnesium monotherapy studies were not found. There is no well- controlled clinical trial investigating the efficacy and safety-of magnesium for treating ADHD. In addition, the safety of magnesium in ADHD is ignored. Therefore, until further strong evidences for its efficacy and safety are provided, magnesium is not recommended for treating ADHD.
引用
收藏
页码：412 / 417
页数：6
相关论文
共 60 条
  • [1] Stuttering in adults: The acoustic startle response, temperamental traits, and biological factors
    Alm, Per A.
    Risberg, Jarl
    [J]. JOURNAL OF COMMUNICATION DISORDERS, 2007, 40 (01) : 1 - 41
  • [2] Omega-3 fatty acid status in attention-deficit/hyperactivity disorder
    Antalis, Caryl J.
    Stevens, Laura J.
    Campbell, Mary
    Pazdro, Robert
    Ericson, Karen
    Burgess, John R.
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (4-5): : 299 - 308
  • [3] Altered Biochemical Parameters in Saliva of Pediatric Attention Deficit Hyperactivity Disorder
    Archana, E.
    Pai, Priya
    Prabhu, Bhavya K.
    Shenoy, Revathi P.
    Prabhu, Krishnananda
    Rao, Anjali
    [J]. NEUROCHEMICAL RESEARCH, 2012, 37 (02) : 330 - 334
  • [4] Serum zinc correlates with parent- and teacher-rated inattention in children with attention-deficit/hyperactivity disorder
    Arnold, LE
    Bozzolo, H
    Hollway, J
    Cook, A
    DiSilvestro, RA
    Bozzolo, DR
    Crowl, L
    Ramadan, Y
    Williams, C
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (04) : 628 - 636
  • [5] Arnold LE, 2001, ANN NY ACAD SCI, V931, P310
  • [6] Baerlocher Kurt, 2003, MMW Fortschr Med, V145, P65
  • [7] Non-stimulant medications in the treatment of ADHD
    Banaschewski, T
    Roessner, V
    Dittmann, RW
    Santosh, PJ
    Rothenberger, A
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2004, 13 (Suppl 1) : 102 - 116
  • [8] Berdonces J L, 2001, Rev Enferm, V24, P11
  • [9] Bourre JM, 2006, J NUTR HEALTH AGING, V10, P377
  • [10] Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium
    Cardoso, Chandra C.
    Lobato, Kelly R.
    Binfare, Ricardo W.
    Ferreira, Priscilla K.
    Rosa, Angelo O.
    Santos, Adair Roberto S.
    Rodrigues, Ana Lucia S.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (02) : 235 - 242
123456